On January 4th, the world's first dynamic genetic testing research results and transformation application conference was held in Beijing. At the press conference, 81-year-old Chinese scientist and professor of Harvard Medical School Liu Zongzheng introduced his latest research results - using peripheral blood dynamic gene detection methods, can carry out over 11 major diseases such as liver cancer, lung cancer and breast cancer. Early screening.
Liu Zongzheng introduced that this method of detection only needs to collect one milliliter of blood from the human body, which can realize early detection of major diseases, discover early traces of diseases in the body, realize early prevention and early detection and early treatment, and fundamentally reduce major malignancy such as tumors. Incidence and mortality of the disease.
For this test method, Dr. Cheng Changming of the Chinese Academy of Sciences explained that there are more than 20,000 genes in the human body, the whole DNA sequence is stable, and the number of each gene fragment will change. Some of these dynamic gene expressions are associated with these major diseases. A complex set of research methods is needed to “catch†these dynamic genes to enable early screening and dynamic tracking of the disease.
Liu Zongzheng introduced that through this test, it can also accurately treat major diseases, provide a reliable molecular basis for the diagnosis and treatment of diseases, and effectively avoid over-examination and over-treatment. At present, Liu Zongzheng entrusted this research result to Huaxia Kyoto Medical Investment Management Co., Ltd. for market operation and promoted the transformation and utilization of scientific research results.
Source: Xinhuanet
Ultrasonic Tissue Dissector Series，Ultrasonic Surgical Scalpe，Ultrasonic Tissue Dissector, Ultrasonic Tissue Dissector
Changzhou Ziying Metal Products Co., Ltd , https://www.ziyingmetal.com